Clearmind Medicine is looking for healthy volunteers aged 18–60 to take part in a trial using MEAI – a novel non-hallucinogenic psychedelic. We are studying the tolerability and safety of MEAI in healthy volunteers. Participants will receive single doses of MEAI, and the study involves around 36-hour admittance at the facility. The clinical trial will take place in Johns Hopkins School of Medicine, Baltimore, MD, USA. Principal Investigator: Jennifer Ellis, PhD.
Participation involves 3 in-person visits and 2 telephone visits. Participation is confidential, and compensation will be provided for your time. Call 4105507923 for more information. Principal Investigator: Jennifer Ellis, PhD. Study Number: IRB00386649.
